Anx

Ingredient matches for Anx

Hydroxyzine

Hydroxyzine hydrochloride (a derivative of Hydroxyzine) is reported as an ingredient of Anx in the following countries:

• United States

International Drug Name Search

Azelone

Azelone may be available in the countries listed below.

Ingredient matches for Azelone

Azelastine

Azelastine hydrochloride (a derivative of Azelastine) is reported as an ingredient of Azelone in the following countries:

• Philippines

International Drug Name Search

Amplisol

Amplisol may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amplisol

Ampicillin

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Amplisol in the following countries:

• Italy

International Drug Name Search

Magnésium Véto Veine

Magnésium Véto Veine may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Magnésium Véto Veine

Magnesium Sulfate

Magnesium Sulfate is reported as an ingredient of Magnésium Véto Veine in the following countries:

• France

International Drug Name Search

Provigil

Provigil is a brand name of modafinil, approved by the FDA in the following formulation(s):

PROVIGIL (modafinil - tablet; oral)

• 
  Manufacturer: CEPHALON
  
  Approval date: December 24, 1998
  
  Strength(s): 100MG, 200MG ^[RLD]

Has a generic version of Provigil been approved?

No. There is currently no therapeutically equivalent version of Provigil available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Provigil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmaceutical formulations of modafinil
  Patent 7,297,346
  Issued: November 20, 2007
  Inventor(s): Corvari; Vincent & Grandolfi; George & Parikh; Alpa
  Assignee(s): Cephalon Inc.
  The present invention is related to compositions of modafinil, including compositions of modafinil and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof.
  
  Patent expiration dates:
  
  
  • November 29, 2023
    
    ✓ 
    Drug product
  
  
  
  • May 29, 2024
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Acetamide derivative having defined particle size
  Patent RE37516
  Issued: January 15, 2002
  Inventor(s): Peter E.; Grebow & Vincent; Corvari & David; Stong
  Assignee(s): Cephalon, Inc.
  Pharmaceutical compositions comprising modafinil in the form of particles of defined size. The particle size of modafinil can have a significant effect on the potency and safety profile of the drug.
  
  Patent expiration dates:
  
  
  • October 6, 2014
    
    ✓ 
    Patent use: IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY
  
  
  
  • April 6, 2015
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Provigil Consumer Information (Drugs.com)
• Provigil Consumer Information (Wolters Kluwer)
• Provigil Consumer Information (Cerner Multum)
• Provigil Advanced Consumer Information (Micromedex)
• Provigil AHFS DI Monographs (ASHP)
• Modafinil Consumer Information (Wolters Kluwer)
• Modafinil Consumer Information (Cerner Multum)
• Modafinil Advanced Consumer Information (Micromedex)
• Modafinil AHFS DI Monographs (ASHP)

Bumetin

Bumetin may be available in the countries listed below.

Ingredient matches for Bumetin

Trimebutine

Trimebutine maleate (a derivative of Trimebutine) is reported as an ingredient of Bumetin in the following countries:

• Colombia


• Venezuela

International Drug Name Search

Marcaine Spinal

In the US, Marcaine Spinal (bupivacaine systemic) is a member of the drug class local injectable anesthetics and is used to treat Cesarean Section and Local Anesthesia.

US matches:

• Marcaine Spinal Solution


• Marcaine Spinal

Ingredient matches for Marcaine Spinal

Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Marcaine Spinal in the following countries:

• Czech Republic


• Israel


• New Zealand


• Romania


• Serbia


• Thailand

International Drug Name Search